Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Industry News

Micell Technologies Receives CE Mark Approval for MiStent SES

June 12, 2013

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

November 10, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Industry News

Miracor to report successful clinical study results of its PICSO® system designed to improve myocardial perfusion following primary PCI

November 04, 2011

News Industry News

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

August 01, 2011

News Industry News

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

July 26, 2011

News Industry News

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

June 29, 2011

News Industry News

Johns Hopkins to Address Topics in Atrial Fibrillation, Interventional Cardiology and Lipids Live Online at CardioCareLive June 28th and 29th

May 24, 2011

News Industry News

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

March 03, 2011

Advertisement

Micell Technologies Receives CE Mark Approval for MiStent SES

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Miracor to report successful clinical study results of its PICSO® system designed to improve myocardial perfusion following primary PCI

NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

Johns Hopkins to Address Topics in Atrial Fibrillation, Interventional Cardiology and Lipids Live Online at CardioCareLive June 28th and 29th

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content